Nicola Fazaa1,#, Kamil Malshy2,#,*, Yuval Shafran1, Ameer Nsair1, Etan Eigner1, Melissa Atallah1, Shadie Badaan1, Kirolos Meilika2, Ariel Zisman1
Canadian Journal of Urology, Vol.33, No.3, pp. 515-526, 2026, DOI:10.32604/cju.2026.076687
- 29 June 2026
Abstract Urethral stricture disease remains a challenging clinical entity within contemporary urology, requiring interventions that achieve sustained urethral patency while preserving functional outcomes. Established modalities such as urethral dilation, endoscopic urethrotomy, and urethroplasty using autologous grafts provide effective treatment for many patients. However, they are constrained by morbidity, graft contraction, and suboptimal success in complex or recurrent strictures. These inherent limitations have stimulated growing investigation of therapeutic strategies. Among device-based innovations, drug-coated balloon dilation, exemplified by the Optilume™, combines mechanical expansion with localized antiproliferative drug delivery and represents a significant evolution in endoscopic management. Pharmacologic adjuncts… More >